Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Kestra Medical Techs Raises FY2026 Sales Guidance from $85.000M to $88.000M vs $85.074M Est

Author: Benzinga Newsdesk | September 11, 2025 04:04pm
Kestra Medical Techs (NASDAQ:KMTS) raises FY2026 sales outlook from $85.000 million to $88.000 million vs $85.074 million estimate.

Posted In: KMTS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist